Adoptive Immune Therapy and Molecular Imaging
Adoptive immune therapy is an exciting new area of oncology therapeutic development, and one uniquely suited to molecular imaging. Fundamentally it is the ability of molecular imaging that allows for in-vivo tracking of the immune cells in the circulation – sequestration in normal organs (spleen and liver) and localization in the target tumor. A wide range of cells can be tracked. BioLaurus continues to lead in the in-vivo immune cell therapeutics imaging space through its capabilities in in-vitro cell labeling and in-vivo cell tracking by a variety of modalities. While much of the research today is focused on rodent oncology models, BioLaurus continues to expand its capabilities in performing cell trafficking studies in larger animals and non-human primates.